The omicron variant of the coronavirus may partially evade the protection of the vaccine against the COVID-19 from Pfizer Inc and its partner BioNTech, Bloomberg News reported, citing the head of research for a laboratory at the African Health Research Institute in South Africa.
His evasion is not complete and a booster injection could provide more protection, according to the report, which quotes Alex Sigal, head of the laboratory.
The omicron variant, first detected in southern Africa last month, has raised alarms around the world over the risk of another surge in infections, with more than two dozen countries, from Japan to the United States, reporting cases.
The World Health Organization (WHO) On Nov. 26, omicron classified it as a “variant of concern,” but said there was no evidence to support the need for new vaccines specifically designed to address it.
Sigal did not immediately respond to a Reuters request for comment.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
